Dana-Farber Cancer Institute

This is your central portal for breaking news, the latest research and important updates from Dana-Farber Cancer Institute. Bookmark this page and check back often for updates.

Meeting NewsVideo

VIDEO: Symposium offers research, mentorship opportunities

November 3, 2017
MIAMI Toni K. Choueiri, MD, from Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, interviews two members of the Scientific…
Meeting NewsVideo

VIDEO: Geographic location plays role in renal cell carcinoma outcomes

November 3, 2017
MIAMI Toni K. Choueiri, MD, from Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center, discusses how treatment center location may…
Meeting News

Secondary data analysis offers ‘high-impact’ approach to improving patient care

November 3, 2017
MIAMI Secondary data analysis enables researchers to provide high-impact data; however, implementation of this approach can be complex, Maxine Sun

Three clinicians elected to ASH executive committee

November 1, 2017
ASH today announced the election of three new members to its executive committee. Stephanie Lee, MD — member of Fred Hutchinson Cancer…

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

October 17, 2017
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer…

Hematologists, oncologists elected to National Academy of Medicine

October 16, 2017
The National Academy of Medicine today announced the election of 70 regular members and 10 international members. Election to the academy —…

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of…
Meeting News

Cabozantinib extends PFS as first-line therapy for metastatic renal cell carcinoma

September 11, 2017
MADRID — Cabozantinib significantly extended PFS compared with sunitinib as initial targeted therapy for patients with metastatic renal cell…
FDA NewsPerspective

FDA approves Kymriah as first chimeric antigen receptor T-cell therapy

August 30, 2017
The FDA approved tisagenlecleucel T-suspension for the treatment of children and young adults with B-cell acute lymphoblastic leukemia…
In the Journals Plus

Metastasis-free survival viable endpoint for prostate cancer trials

August 29, 2017
Metastasis-free survival could be a surrogate endpoint for OS in clinical trials designed to evaluate adjuvant therapy options for patients with…

The University of Texas MD Anderson Cancer Center named best cancer hospital in nation

August 8, 2017
The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country. MD Anderson tops U.S
In the Journals Plus

Platinum-based chemotherapy shows efficacy in BRCA2-mutated prostate cancer

August 2, 2017
A small group of men with metastatic, castration-resistant prostate

No Stomach For Cancer awards grants to support stomach cancer research

July 18, 2017
No Stomach For Cancer awarded $100,000 worth of grants to fund research related to immunotherapy and use of blood biomarkers to predict early…
Cover Story

Deeper understanding of disease biology may expand sarcoma treatment options

HemOnc Today, July 10, 2017
Sarcomas are the most common tumors in young adults, and they account for 15% of all pediatric cancers. Approximately 12,390 cases are expected to be…
Meeting News

Enzyme activator could be ‘disease-modifying’ treatment for pyruvate kinase deficiency

June 28, 2017
Enzyme activator AG-348 sustained hemoglobin increases in adults with pyruvate kinase deficiency, according to updated data from a phase 2 trial…

St. Jude Children’s Research Hospital named nation’s best for pediatric cancer

June 27, 2017
St. Jude Children’s Research Hospital has been named the best hospital in the nation for children with cancer. The institution tops U.S. News
In the Journals Plus

Midostaurin extends survival in acute myeloid leukemia with FLT3 mutation

June 23, 2017
The addition of midostaurin to standard chemotherapy improved OS and EFS among patients with acute myeloid leukemia and FLT3 mutation, according to…

Warren Alpert Foundation recognizes leaders in cancer immunology

June 13, 2017
Five scientists will receive the Warren Alpert Foundation Prize in recognition of their discoveries in the field of cancer immunology. The…
FDA News

FDA grants orphan drug designation to tucatinib for brain metastases

June 13, 2017
The FDA granted orphan drug designation to tucatinib for the treatment of patients with breast cancer whose disease metastasized to the brain…
Meeting News

Mastectomy more common among US women with triple-negative breast cancer

June 4, 2017
CHICAGO — Women in the United States who underwent neoadjuvant therapy for triple-negative breast cancer appeared more likely than those in…